CHARLESTON, S.C., March 14, 2012 (GLOBE NEWSWIRE) -- Revolutions Medical Corporation ("Revolutions Medical" or the "Company") (OTCQB:RMCP) announces that it has received and accepted a purchase order for six hundred cases, totaling 480,000 units of the Company's 3ml RevVac™ auto-retractable vacuum safety syringe from a new customer for the healthcare market in Mexico.
The Company, which began full-scale production this month, expects to deliver the shipping container in April 2012, once it has received a Mexican Import Permit. The Company anticipates a relatively easy permit process, as the RevVac™ safety syringe is cleared by the FDA and manufactured to meet ISO 13485 compliance quality requirements. Further, the Company has been issued a patent (# MX/a/2008/003897) in Mexico.
Ron Wheet, Chief Executive Officer and Chairman of Revolutions Medical, stated, "We are confident that our new customer, and healthcare professionals in Mexico, will appreciate the quality and benefits offered by our RevVac™ safety syringe."
About Revolutions Medical Corporation
Revolutions Medical is a safety medical device and software application company. Its products include the RevVac™ Safety Syringe (FDA cleared), safety blood drawing device, the RevColor™, RevDisplay™, and Rev3D™ software tools that are compatible with standard MRIs and standard Picture Archiving Computer Systems (PACS).
For additional information, please visit Revolutions Medical corporate website:
http://www.revolutionsmedical.com/
To be added to the Revolutions Medical investor email list, please email:
investment@revolutionsmedical.com with RMCP in the subject line.
FORWARD-LOOKING STATEMENTS
The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.